Biofrontera AG, Leverkusen: Publication pursuant to Section 111c AktG for distribution throughout EuropeConvertible Bond Agreement • March 12th, 2020 • Biofrontera AG • Pharmaceutical preparations
On March 11, 2020, Biofrontera AG, Leverkusen (“Company”) has entered into an agreement with Maruho Deutschland GmbH, Düsseldorf (“Lender”) to support the ongoing capital market activities of the Company as described below (“Agreement” or “Contract”). The Lender holds more than 20 % of the shares in the Company and is therefore a related party within the meaning of Section 111a (1) of the German Stock Corporation Act (AktG).
